Efficacy and safety of ustekinumab and vedolizumab in very early-onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN.

Luca Scarallo, Paolo Lionetti, Jaroslaw Kierkus, Lauren Collen, Victoria Riedl, Christian Jakobsen, Gemma Pujol-Muncunill, Kaija-Leena Kolho, Marta Velasco Rodriguez-Belvis, Katarina Mitrova, Darja Urlep, Benedicte Pigneur, Seamus Hussey, Firas Rinawi, Jan De Laffolie, Karl Mårild, Anat Yerushalmy-Feler, Raffi Lev Tzion, Maya Granot, Marina Aloi, Elisabeth De Greef, Christos Tzvinikos, Christoph Norden, Caterina Strisciuglio, Kwang Yang Lee, Rémi Duclaux-Loras, Saverio Pochesci, Naire Sansotta, Pejman Rohani, Dror S Shouval, Yael Weintraub, CEDATA Group

DOI: 10.1002/jpn3.70645

На странице источника доступны аннотация, полный текст или сведения о том, где его прочитать.